 |
|
|
|
|
|
|
|
|
|
|
|
1 to 5 of 5 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Weggen S. on PAPER: Coric V. et al., 2012, This study describing Phase 2 results of the γ-secretase inhibitor avagacestat comes down to two... 27 Nov 2012.
|
|
|
 |
|
|
Bulic B, Weggen S. on PAPER: Ebke A. et al., 2011, Comment by Sascha Weggen, Thorsten Jumpertz, Andreas Rennhack, Bruno Bulic
Despite... 19 Sep 2011.
|
|
|
|
|
|
Weggen S. on NEWS: Barcelona: Allosteric γ Modulation Moves Toward Clinic, Comment by Sascha Weggen and Stefanie Hahn
To understand how presenilin mutations... 5 Apr 2011.
|
|
|
|
|
|
Bulic B, Weggen S. on PAPER: Beel AJ. et al., 2009, Strong evidence has been provided that γ-secretase modulators (GSMs) directly affect enzyme... 2 Dec 2009.
|
|
|
|
|
|
Weggen S. on NEWS: The AICD Test? Transgenic Mice Show Neurodegeneration, The role and significance of the APP intracellular domain (AICD) has remained puzzling to many... 16 Oct 2009.
|
|
|
|
|
|
|
1 to 5 of 5 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
See our latest Webinar: 
